Crossmark

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)

Crossref DOI link: https://doi.org/10.1007/s11547-022-01511-7

Published Online: 2022-06-28

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Francolini, Giulio

Detti, Beatrice https://orcid.org/0000-0001-5799-5924
Di Cataldo, Vanessa

Garlatti, Pietro

Aquilano, Michele

Allegra, Andrea

Lucidi, Sara

Cerbai, Cecilia

Ciccone, Lucia Pia

Salvestrini, Viola

Stocchi, Giulia

Guerrieri, Barbara

Visani, Luca

Loi, Mauro

Desideri, Isacco

Mangoni, Monica

Meattini, Icro

Livi, Lorenzo
Funding

Funding for this research was provided by:

Università degli Studi di Firenze
License Information

Text and Data Mining valid from 2022-06-28

Version of Record valid from 2022-06-28
More Information

Article History

Received: 31 December 2021

Accepted: 30 May 2022

First Online: 28 June 2022

Declarations

:

: The authors have not disclosed any competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below